TNC and juvenile idiopathic arthritis: These results indicate that the therapeutic effect of etanercept, confirmed by improved JADAS scores, is accompanied by changes in adipokine and tenascin C profiles toward levels observed in healthy individuals, highlighting the potential of these biomarkers for monitoring the response to JIA treatment.